Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial.
Jennifer McNeely, Geetha A Subramaniam, Rebecca Stone et al.
✦ AI-curated · Sources linked
In 30 seconds
The STOP randomized controlled trial evaluated a collaborative care intervention aimed at reducing risky opioid use among primary care patients. Conducted across five U.S. sites, the study involved 202 patients with current risky opioid use. Results showed that while the intervention did not significantly reduce mean days of risky opioid use compared to enhanced usual care, fewer participants in the STOP group progressed to moderate-severe opioid use disorder at 6 months.
Key findings
- Mean days of risky opioid use at 180 days were 12.2 in STOP vs 15.5 in EUC.
- Only 1.1% of STOP participants developed moderate-severe OUD at 6 months compared to 11.4% in EUC.
- At 12 months, 3.4% of STOP participants had moderate-severe OUD vs 5.3% in EUC.
Why it matters
This study highlights the challenges in reducing risky opioid use in primary care settings, particularly among patients with significant pain and comorbidities. Understanding the effectiveness of collaborative care interventions can inform future strategies to address opioid misuse.